Sort by
Refine Your Search
-
Listed
-
Country
-
Employer
- University of North Carolina at Chapel Hill
- Fred Hutchinson Cancer Center
- THE UNIVERSITY OF HONG KONG
- Medical College of Wisconsin
- Nature Careers
- The Ohio State University
- University of Maryland, Baltimore
- University of Washington
- Biobizkaia Health Research Institute
- Deutsches Krebsforschungszentrum
- Duke University
- Duke University Medical Center
- Emory University
- Erasmus MC (University Medical Center Rotterdam)
- George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureș
- Instituto de Investigacion Sanitaria de Navarra (IdiSNA)
- Lunds universitet
- McGill University
- Rutgers University
- Stanford University
- The International Institute of Molecular Mechanisms
- University of Colorado
- University of Dundee;
- University of Gdansk
- University of Texas at Tyler
- Vanderbilt University
- Washington State University
- 17 more »
- « less
-
Field
-
funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description Work group: HI-TRON Mainz - Personalized Immunotherapies Area of research: Scientific
-
in T cell-based immunotherapy (it might include CAR T cells), including studies on in vitro T cell-cancer cell interactions demonstrated by the first authorship in a peer-reviewed publication. While
-
people’s lives taking research a step beyond the lab. Research projects we are looking to pursue are in the areas of extracellular vesicles & cell therapy, immunotherapy, nucleic acids therapeutics
-
George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureș | Romania | 21 days ago
job funded through the EU Research Framework Programme? Other EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description Immunotherapy, translational
-
of white blood cell, impact cancer immunotherapy. Immunotherapies like immune checkpoint inhibitors (ICIs) have revolutionised cancer treatment, but resistance remains a challenge. The TUNIC project will
-
to elucidate how T cell-NK cell interactions, immune regulatory circuits, and cellular state transitions shape responsiveness to cancer immunotherapies. Research efforts will extend to therapeutic
-
“CAR-T Cell Immunotherapy against Stromal Antigens for the Treatment of PDAC (CAR4PDAC)” under the direction of Drs. Juan José Lasarte and Felipe Prosper. The project is funded by the AECC Foundation
-
approaches to immunotherapies. The focus of the ICCVS is the development of personalized vaccine against non-small cell lung cancer (NSCLC). The approach is based on the use of cancer specific T cells
-
solid tumors, with a special emphasis on breast cancer. Our discoveries so far include showing how myeloid cell heterogeneity contributes to immunotherapy resistance and revealing how the bone
-
: CRI’s International Cancer Immunotherapy Conference (CICON) and CRI’s Bioinformatics Bootcamp Apply for a Fellowship Join the Global Immunotherapy Community at CICON25 If you’re interested in connecting